Lerner Neil bought CMPX
September 24, 2026 · Form 4 insider transaction
Lerner Neil bought 2,500 shares of Compass Therapeutics, Inc. at $1.14 per share, a transaction worth $2.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,500
Price
$1.14
Total value
$2.9K
InsiderLerner Neil
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 24, 2026
Filing dateSeptember 25, 2026
Shares owned after400,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
62,500 of the shares represents unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027.